Patterns of Chemotherapy Utilization among Elderly Patients with Early-Stage Triple-Negative Breast Cancer

被引：0
|
作者：
Malinowski, Catalina
Lei, Xiudong
Giordano, Sharon
Chavez, Marianna
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO3-03-07
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO3-03-07
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Cost and healthcare resource utilization (HCRU) for patients receiving neoadjuvant therapy for early-stage triple-negative breast cancer (ESTNBC)
    Rhodes, W. C.
    Gautam, S.
    Haiderali, A.
    Huang, M.
    Sieluk, J.
    Skinner, K. E.
    Schwartzberg, L. S.
    ANNALS OF ONCOLOGY, 2020, 31 : S51 - S51
  • [42] Geriatric Early-Stage Triple-Negative Breast Cancer Patients in Low-risk Population: Omitting Chemotherapy Based on Nomogram
    Zhou, Chen
    Xu, Li
    Du, Zhenggui
    Lv, Qing
    CLINICAL BREAST CANCER, 2022, 22 (08) : 771 - 780
  • [43] Adjuvant addition of capecitabine to early-stage triple-negative breast cancer patients receiving standard chemotherapy: a meta-analysis
    Li, Yan
    Zhou, Yidong
    Mao, Feng
    Lin, Yan
    Zhang, Xiaohui
    Shen, Songjie
    Sun, Qiang
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 179 (03) : 533 - 542
  • [44] Adjuvant capecitabine-containing chemotherapy benefit and homologous recombination deficiency in early-stage triple-negative breast cancer patients
    de Boo, Leonora W.
    Jozwiak, Katarzyna
    Joensuu, Heikki
    Lindman, Henrik
    Lauttia, Susanna
    Opdam, Mark
    van Steenis, Charlaine
    Brugman, Wim
    Kluin, Roelof J. C.
    Schouten, Philip C.
    Kok, Marleen
    Nederlof, Petra M.
    Hauptmann, Michael
    Linn, Sabine C.
    BRITISH JOURNAL OF CANCER, 2022, 126 (10) : 1401 - 1409
  • [45] Adjuvant capecitabine-containing chemotherapy benefit and homologous recombination deficiency in early-stage triple-negative breast cancer patients
    Leonora W. de Boo
    Katarzyna Jóźwiak
    Heikki Joensuu
    Henrik Lindman
    Susanna Lauttia
    Mark Opdam
    Charlaine van Steenis
    Wim Brugman
    Roelof J. C. Kluin
    Philip C. Schouten
    Marleen Kok
    Petra M. Nederlof
    Michael Hauptmann
    Sabine C. Linn
    British Journal of Cancer, 2022, 126 : 1401 - 1409
  • [46] Adjuvant addition of capecitabine to early-stage triple-negative breast cancer patients receiving standard chemotherapy: a meta-analysis
    Yan Li
    Yidong Zhou
    Feng Mao
    Yan Lin
    Xiaohui Zhang
    Songjie Shen
    Qiang Sun
    Breast Cancer Research and Treatment, 2020, 179 : 533 - 542
  • [47] Platinum chemotherapy for early triple-negative breast cancer
    Mason, Sofia RE.
    Willson, Melina L.
    Egger, Sam J.
    Beith, Jane
    Dear, Rachel F.
    Goodwin, Annabel
    BREAST, 2024, 75
  • [48] Patterns of survival and efficacy of chemotherapy in elderly patients with triple-negative breast cancer treated in the neoadjuvant setting
    Gordeeva, Olga
    Kolyadina, Irina
    Zhukova, Lyudmila
    Ganshina, Inna
    Komov, Dmitry
    Meshcheryakov, Andrey
    CANCER RESEARCH, 2020, 80 (04)
  • [49] Older patients with early-stage triple-negative breast cancer: The Memorial Sloan Kettering Cancer Center experience
    Zhi, Iris
    Lake, Diana E.
    Ehrich, Fiona
    Chen, Yuan
    Korc-Grodzicki, Beatriz
    Norton, Larry
    Robson, Mark E.
    Singh, Jasmeet Chadha
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [50] Cancer recurrence and survival in patients with early-stage triple-negative breast cancer in a US local oncology practice
    Zhao, L.
    Seal, B. S.
    Feinberg, B. A.
    Gilmore, J. W.
    Haislip, S.
    Sullivan, S. D.
    Christiansen, N. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345